The antibody 34bE12, available from A Menarini Diagnostics, recognises cytokeratin 1, 5, 10 and 14. It reacts with squamous and adenosquamous cell carcinomas, while adenocarcinoma is negative. In normal tissue, 34bE12 stains stratified epithelia, myoepithelial cells and basal cells in the prostate gland and bronchus. Thus, it is useful as a differential marker for squamous carcinoma and adenocarcinoma as well as for benign and malignant tumours of the prostate gland.
Other News
Latest Issues
UK NEQAS IMPROVES PATIENT CARE
We aim to improve patient care through monitoring the quality of tests and their reporting, in an independent manner and on a not-for-profit basis.
We are here to help ensure optimal quality in testing for the benefit of patients.
We believe that the result of tests should be:
BDIAP Molecular Pathology Study Day
10 Union Street, London, SE1 1SZ
2 March, 2026
UK NEQAS webinar: Introduction to Cellular Components, Tissue Morphology and Tissue Recognition
Online
3-4 March, 2026
Cell & Gene Therapy 2026
Hinxton Hall Conference Centre, Wellcome Genome Campus, Hinxton, CB10 1RQ
9-10 March, 2026
UK NEQAS webinar: Specialist Demonstration of Lipids, Pigments, Minerals, and Infections
Online
10-11 March, 2026
USCAP 115th Annual Meeting
Henry B. González Convention Center, San Antonio, Texas, USA
21-26 March, 2026